Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amthamine is a potent and highly selective agonist of the histamine H2 receptor. It is a small molecule used primarily as a research tool to study the physiological and pharmacological roles of H2 receptors, particularly in gastric acid secretion and vascular function. Amthamine acts as a full agonist at the H2 receptor, with little or no activity at H1 or H3 receptors. In experimental models, it induces dose-dependent increases in gastric acid secretion and has been shown to be more effective than other related compounds such as dimaprit. Its effects are competitively antagonized by known H2 receptor antagonists like famotidine and ranitidine[1][3][7][9]. Amthamine has also been used to investigate vascular protective mechanisms in brain endothelial cells[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on amthamine.